Osteocalcin Gene Expression Is Regulated by Wild-Type p53

被引:10
作者
Chen, Hankui [1 ]
Hays, Emily [1 ]
Liboon, Jay [1 ]
Neely, Chris [1 ]
Kolman, Kevin [1 ]
Chandar, Nalini [1 ]
机构
[1] Midwestern Univ, Chicago Coll Osteopath Med, Dept Biochem, Downers Grove, IL 60515 USA
基金
美国国家卫生研究院;
关键词
Osteoblast differentiation; Gene regulation; Osteocalcin; p53; OSTEOSARCOMA CELL-LINE; OSTEOBLAST DIFFERENTIATION; DIRECT TARGET; DNA-SEQUENCE; BONE; IDENTIFICATION; BINDING; PROTEIN; RECEPTOR; REPRESSION;
D O I
10.1007/s00223-011-9533-x
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
The tumor-suppressor p53 is a transcription factor that regulates a number of genes in the process of cell-cycle inhibition, apoptosis, and DNA damage. Recent studies have revealed a crucial role for p53 in bone remodeling. In our previous studies we have shown that p53 is an important regulator of osteoblast differentiation. In this study we investigated the role of p53 in the regulation of human osteocalcin gene expression. We observed that osteocalcin promoter activity could be upregulated by both exogenous and endogenous p53 and downregulated by p53-specific small interfering RNA. DNA affinity immunoblotting assay showed that p53 can bind to the human osteocalcin promoter in vitro. We further identified a p53 response element within the osteocalcin promoter region using a chromatin immunoprecipitation assay. Furthermore, we observed an additive effect of p53 and VDR on the regulation of osteocalcin promoter activity. Our findings suggest that p53 may directly target the human osteocalcin gene and positively affect osteocalcin gene expression.
引用
收藏
页码:411 / 418
页数:8
相关论文
共 36 条
[1]
Involvement of p53 in cell differentiation and development [J].
Almog, N ;
Rotter, V .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1997, 1333 (01) :F1-F27
[2]
ALONIGRINSTEIN R, 1993, ONCOGENE, V8, P3297
[3]
p53 is involved in the differentiation but not in the differentiation-associated apoptosis of myoblasts [J].
M A Cerone ;
A Marchetti ;
G Bossi ;
G Blandino ;
A Sacchi ;
S Soddu .
Cell Death & Differentiation, 2000, 7 (5) :506-508
[4]
INACTIVATION OF P53 GENE IN HUMAN AND MURINE OSTEOSARCOMA CELLS [J].
CHANDAR, N ;
BILLIG, B ;
MCMASTER, J ;
NOVAK, J .
BRITISH JOURNAL OF CANCER, 1992, 65 (02) :208-214
[5]
DEPENDENCE OF INDUCTION OF OSTEOCALCIN GENE-EXPRESSION ON THE PRESENCE OF WILD-TYPE P53 IN A MURINE OSTEOSARCOMA CELL-LINE [J].
CHANDAR, N ;
CAMPBELL, P ;
NOVAK, J ;
SMITH, M .
MOLECULAR CARCINOGENESIS, 1993, 8 (04) :299-305
[6]
Chandar N, 2000, ANTICANCER RES, V20, P2553
[7]
Relationship of bone morphogenetic protein expression during osteoblast differentiation to wild type p53 [J].
Chandar, N ;
Swindle, J ;
Szajkovics, A ;
Kolman, K .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2005, 23 (06) :1345-1353
[8]
DUCY P, 1995, MOL CELL BIOL, V15, P1858
[9]
Increased bone formation in osteocalcin-deficient mice [J].
Ducy, P ;
Desbois, C ;
Boyce, B ;
Pinero, G ;
Story, B ;
Dunstan, C ;
Smith, E ;
Bonadio, J ;
Goldstein, S ;
Gundberg, C ;
Bradley, A ;
Karsenty, G .
NATURE, 1996, 382 (6590) :448-452
[10]
DEFINITION OF A CONSENSUS BINDING-SITE FOR P53 [J].
ELDEIRY, WS ;
KERN, SE ;
PIETENPOL, JA ;
KINZLER, KW ;
VOGELSTEIN, B .
NATURE GENETICS, 1992, 1 (01) :45-49